Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J K Cowell

Showing results (101-110 of 131) with videos related to

Pageof 14
Sort By:
Oncogene|November 14, 2006
The EVI5 TBC domain provides the GTPase-activating protein motif for RAB11J T S Dabbeekeh, S L Faitar, C P Dufresne, et al.
Disease Markers|October 1, 1989
Assignment of an anonymous DNA sequence IB/D22 (DXS371) to XP11.1-11.4N K Spurr, C Mitchell, A C Gough, et al.
Blood|October 24, 1997
Molecular characterization of the t(8;13)(p11;q12) translocation associated with an atypical myeloproliferative disorder: evidence for three discrete loci involved in myeloid leukemias on 8p11I H Still, O Chernova, D Hurd, et al.
Experimental and Molecular Pathology|July 13, 2010
Distinct molecular signatures in pediatric infratentorial glioblastomas defined by aCGHS Sharma, A Free, Y Mei, et al.
Oncogene|June 10, 1998
Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosisY Kondo, S Kondo, Y Tanaka, et al.
Oncogene|November 1, 1990
Preferential loss of maternal alleles in sporadic Wilms' tumourN Pal, R B Wadey, B Buckle, et al.
Oncogene|November 1, 1992
Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndromeP N Baird, N Groves, D A Haber, et al.
Oncogene|June 1, 1990
Loss of heterozygosity in Wilms' tumour involves two distinct regions of chromosome 11R B Wadey, N Pal, B Buckle, et al.
Oncogene|October 31, 1998
Molecular analysis of two putative tumour suppressor genes, PTEN and DMBT, which have been implicated in glioblastoma multiforme disease progressionR P Somerville, Y Shoshan, C Eng, et al.
British Journal of Cancer|February 19, 2004
Identification and characterisation of constitutional chromosome abnormalities using arrays of bacterial artificial chromosomesJ K Cowell, Y D Wang, K Head, et al.
Pageof 14

Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
Oncogene|November 14, 2006
The EVI5 TBC domain provides the GTPase-activating protein motif for RAB11J T S Dabbeekeh, S L Faitar, C P Dufresne, et al.
Disease Markers|October 1, 1989
Assignment of an anonymous DNA sequence IB/D22 (DXS371) to XP11.1-11.4N K Spurr, C Mitchell, A C Gough, et al.
Blood|October 24, 1997
Molecular characterization of the t(8;13)(p11;q12) translocation associated with an atypical myeloproliferative disorder: evidence for three discrete loci involved in myeloid leukemias on 8p11I H Still, O Chernova, D Hurd, et al.
Experimental and Molecular Pathology|July 13, 2010
Distinct molecular signatures in pediatric infratentorial glioblastomas defined by aCGHS Sharma, A Free, Y Mei, et al.
Oncogene|June 10, 1998
Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosisY Kondo, S Kondo, Y Tanaka, et al.
Oncogene|November 1, 1990
Preferential loss of maternal alleles in sporadic Wilms' tumourN Pal, R B Wadey, B Buckle, et al.
Oncogene|November 1, 1992
Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndromeP N Baird, N Groves, D A Haber, et al.
Oncogene|June 1, 1990
Loss of heterozygosity in Wilms' tumour involves two distinct regions of chromosome 11R B Wadey, N Pal, B Buckle, et al.
Oncogene|October 31, 1998
Molecular analysis of two putative tumour suppressor genes, PTEN and DMBT, which have been implicated in glioblastoma multiforme disease progressionR P Somerville, Y Shoshan, C Eng, et al.
British Journal of Cancer|February 19, 2004
Identification and characterisation of constitutional chromosome abnormalities using arrays of bacterial artificial chromosomesJ K Cowell, Y D Wang, K Head, et al.
Pageof 14